Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

579
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
579
Neural Regulation01:37

Neural Regulation

39.5K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.5K
ATP Synthase: Mechanism01:48

ATP Synthase: Mechanism

14.7K
In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased...
14.7K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

283
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
283
Mitochondrial Membranes01:45

Mitochondrial Membranes

11.3K
A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...
11.3K
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Quercetin restores oocyte maturation and embryo development in DEHP-exposed mice via mitochondrial protection and apoptosis inhibition.

Chemico-biological interactions·2026
Same author

Modulation of intra-oceanic trench bending and along-trench thermochemical transport by mantle toroidal flow.

Nature communications·2026
Same author

Kit Ligand enhances in vitro oocyte maturation and early embryonic development in sheep.

Animal reproduction science·2026
Same author

Automated deep learning-based retinoschisis and detachment volume measurement in pathological myopia with posterior scleral contraction.

The British journal of ophthalmology·2026
Same author

Development of a deep learning model to predict cycloplegic myopia and pre- myopia: based on a large-scale screening of school-aged children.

Eye (London, England)·2026
Same author

Active but not passive passengers: Persistent-propagative plant viruses manipulate insect vectors for efficient transmission.

PLoS pathogens·2026

Related Experiment Video

Updated: Jul 13, 2025

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
06:07

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease

Published on: June 23, 2023

1.6K

The interaction between alpha-synuclein and mitochondrial dysfunction in Parkinson's disease.

Hong-Yan Li1, De-Shui Liu2, Ying-Bo Zhang2

  • 1Department of Basic Medical College, Heilongjiang University of Chinese Medicine, Haerbin 150000, PR China.

Biophysical Chemistry
|October 15, 2023
PubMed
Summary

Parkinson's disease involves alpha-synuclein (α-syn) aggregation and mitochondrial dysfunction. This review explores how α-syn impacts mitochondrial health, contributing to Parkinson's disease pathogenesis.

Keywords:
Alpha-synucleinMitochondrial dysfunctionMitochondrial homeostasisParkinson's disease

More Related Videos

Interactions with and Membrane Permeabilization of Brain Mitochondria by Amyloid Fibrils
00:15

Interactions with and Membrane Permeabilization of Brain Mitochondria by Amyloid Fibrils

Published on: September 28, 2019

6.0K
Assessing Mitochondrial Function in Sciatic Nerve by High-Resolution Respirometry
08:19

Assessing Mitochondrial Function in Sciatic Nerve by High-Resolution Respirometry

Published on: May 5, 2022

2.5K

Related Experiment Videos

Last Updated: Jul 13, 2025

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
06:07

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease

Published on: June 23, 2023

1.6K
Interactions with and Membrane Permeabilization of Brain Mitochondria by Amyloid Fibrils
00:15

Interactions with and Membrane Permeabilization of Brain Mitochondria by Amyloid Fibrils

Published on: September 28, 2019

6.0K
Assessing Mitochondrial Function in Sciatic Nerve by High-Resolution Respirometry
08:19

Assessing Mitochondrial Function in Sciatic Nerve by High-Resolution Respirometry

Published on: May 5, 2022

2.5K

Area of Science:

  • Neuroscience
  • Cell Biology
  • Aging Research

Background:

  • Parkinson's disease (PD) is characterized by alpha-synuclein (α-syn) aggregation in Lewy bodies.
  • Mitochondrial dysfunction is increasingly recognized as a key factor in PD pathogenesis.
  • The interplay between α-syn pathology and mitochondrial alterations is crucial for understanding PD.

Purpose of the Study:

  • To review the role of α-syn pathology in Parkinson's disease.
  • To examine mitochondrial alterations observed in PD.
  • To elucidate the mechanisms by which α-syn interacts with mitochondrial homeostasis.

Main Methods:

  • Literature review of studies on α-syn, mitochondria, and PD.
  • Analysis of research linking α-syn aggregation to mitochondrial dysfunction.
  • Synthesis of current understanding of α-syn's impact on mitochondrial homeostasis.

Main Results:

  • α-syn aggregates are found in Lewy bodies and Lewy neurites in PD patients.
  • Mitochondrial dynamics, quality control, and function are impaired in PD.
  • α-syn directly interacts with mitochondria, affecting their structure and function.

Conclusions:

  • α-syn pathology and mitochondrial dysfunction are central to PD pathogenesis.
  • α-syn's interaction with mitochondria disrupts cellular homeostasis.
  • Targeting the α-syn-mitochondria axis may offer therapeutic strategies for PD.